Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 187 entries
Sorted by: Best Match Show Resources per page
Endothelial dysfunction in patients with lone atrial fibrillation.

ARYA atherosclerosis

Heshmat-Ghahdarijani K, Jangjoo S, Amirpour A, Najafian J, Khosravi A, Heidarpour M, Hekmat M, Shafie D.
PMID: 34122581
ARYA Atheroscler. 2020 Nov;16(6):278-283. doi: 10.22122/arya.v16i6.2095.

BACKGROUND: Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with cardiovascular diseases (CVDs) and may have significant complications such as stroke. The present study aims to evaluate endothelial dysfunction in patients with lone atrial fibrillation (LAF) through...

Cite
Heshmat-Ghahdarijani K, Jangjoo S, Amirpour A, et al. Endothelial dysfunction in patients with lone atrial fibrillation. ARYA Atheroscler. 2020;16(6):278-283doi: 10.22122/arya.v16i6.2095.
Heshmat-Ghahdarijani, K., Jangjoo, S., Amirpour, A., Najafian, J., Khosravi, A., Heidarpour, M., Hekmat, M., & Shafie, D. (2020). Endothelial dysfunction in patients with lone atrial fibrillation. ARYA atherosclerosis, 16(6), 278-283. https://doi.org/10.22122/arya.v16i6.2095
Heshmat-Ghahdarijani, Kiyan, et al. "Endothelial dysfunction in patients with lone atrial fibrillation." ARYA atherosclerosis vol. 16,6 (2020): 278-283. doi: https://doi.org/10.22122/arya.v16i6.2095
Heshmat-Ghahdarijani K, Jangjoo S, Amirpour A, Najafian J, Khosravi A, Heidarpour M, Hekmat M, Shafie D. Endothelial dysfunction in patients with lone atrial fibrillation. ARYA Atheroscler. 2020 Nov;16(6):278-283. doi: 10.22122/arya.v16i6.2095. PMID: 34122581; PMCID: PMC8172232.
Copy Download .nbib Format: NLM
Routine diagnostic arthroscopy with elbow ulnar collateral ligament reconstruction does not reduce the need for future valgus extension overload-related surgeries: a systematic review and meta-analysis.

Journal of shoulder and elbow surgery

Looney AM, Bovill JD, Huffman SS, Najarian RG.
PMID: 34478864
J Shoulder Elbow Surg. 2022 Jan;31(1):e22-e36. doi: 10.1016/j.jse.2021.08.004. Epub 2021 Aug 31.

BACKGROUND: Valgus extension overload syndrome (VEOS) most commonly affects overhead athletes and consists of a constellation of conditions involving the medial, posterior, and lateral elbow, with the most widely discussed being ulnar collateral ligament (UCL) injuries. Many athletes with...

Cite
Looney AM, Bovill JD, Huffman SS, et al. Routine diagnostic arthroscopy with elbow ulnar collateral ligament reconstruction does not reduce the need for future valgus extension overload-related surgeries: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2021;31(1):e22-e36doi: 10.1016/j.jse.2021.08.004.
Looney, A. M., Bovill, J. D., Huffman, S. S., & Najarian, R. G. (2022). Routine diagnostic arthroscopy with elbow ulnar collateral ligament reconstruction does not reduce the need for future valgus extension overload-related surgeries: a systematic review and meta-analysis. Journal of shoulder and elbow surgery, 31(1), e22-e36. https://doi.org/10.1016/j.jse.2021.08.004
Looney, Austin M, et al. "Routine diagnostic arthroscopy with elbow ulnar collateral ligament reconstruction does not reduce the need for future valgus extension overload-related surgeries: a systematic review and meta-analysis." Journal of shoulder and elbow surgery vol. 31,1 (2022): e22-e36. doi: https://doi.org/10.1016/j.jse.2021.08.004
Looney AM, Bovill JD, Huffman SS, Najarian RG. Routine diagnostic arthroscopy with elbow ulnar collateral ligament reconstruction does not reduce the need for future valgus extension overload-related surgeries: a systematic review and meta-analysis. J Shoulder Elbow Surg. 2022 Jan;31(1):e22-e36. doi: 10.1016/j.jse.2021.08.004. Epub 2021 Aug 31. PMID: 34478864.
Copy Download .nbib Format: NLM
Erratum to: Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.

Briefings in bioinformatics

Bagherian M, Sabeti E, Wang K, Sartor MA, Nikolovska-Coleska Z, Najarian K.
PMID: 32047893
Brief Bioinform. 2021 Jan 18;22(1):606. doi: 10.1093/bib/bbaa020.

No abstract available.

Cite
Bagherian M, Sabeti E, Wang K, et al. Erratum to: Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform. 2021;22(1):606doi: 10.1093/bib/bbaa020.
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021). Erratum to: Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Briefings in bioinformatics, 22(1), 606. https://doi.org/10.1093/bib/bbaa020
Bagherian, Maryam, et al. "Erratum to: Machine learning approaches and databases for prediction of drug-target interaction: a survey paper." Briefings in bioinformatics vol. 22,1 (2021): 606. doi: https://doi.org/10.1093/bib/bbaa020
Bagherian M, Sabeti E, Wang K, Sartor MA, Nikolovska-Coleska Z, Najarian K. Erratum to: Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform. 2021 Jan 18;22(1):606. doi: 10.1093/bib/bbaa020. PMID: 32047893; PMCID: PMC7820856.
Copy Download .nbib Format: NLM
Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases.

ARYA atherosclerosis

Khosravi A, Vakhshoori M, Sharif V, Roghani-Dehkordi F, Najafian J, Mansouri A.
PMID: 33133207
ARYA Atheroscler. 2020 Mar;16(2):85-93. doi: 10.22122/arya.v16i2.2019.

BACKGROUND: The probable complications of 3 different cardiovascular diseases treatment options including percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG), and medical therapy (MT), especially in individuals suffering from left main (LM) and/or three vessel diseases (3VDs), have...

Cite
Khosravi A, Vakhshoori M, Sharif V, et al. Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases. ARYA Atheroscler. 2020;16(2):85-93doi: 10.22122/arya.v16i2.2019.
Khosravi, A., Vakhshoori, M., Sharif, V., Roghani-Dehkordi, F., Najafian, J., & Mansouri, A. (2020). Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases. ARYA atherosclerosis, 16(2), 85-93. https://doi.org/10.22122/arya.v16i2.2019
Khosravi, Alireza, et al. "Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases." ARYA atherosclerosis vol. 16,2 (2020): 85-93. doi: https://doi.org/10.22122/arya.v16i2.2019
Khosravi A, Vakhshoori M, Sharif V, Roghani-Dehkordi F, Najafian J, Mansouri A. Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases. ARYA Atheroscler. 2020 Mar;16(2):85-93. doi: 10.22122/arya.v16i2.2019. PMID: 33133207; PMCID: PMC7578519.
Copy Download .nbib Format: NLM
Game Theoretic Approach for Systematic Feature Selection; Application in False Alarm Detection in Intensive Care Units.

Entropy (Basel, Switzerland)

Afghah F, Razi A, Soroushmehr R, Ghanbari H, Najarian K.
PMID: 33265281
Entropy (Basel). 2018 Mar 12;20(3). doi: 10.3390/e20030190.

Intensive Care Units (ICUs) are equipped with many sophisticated sensors and monitoring devices to provide the highest quality of care for critically ill patients. However, these devices might generate false alarms that reduce standard of care and result in...

Cite
Afghah F, Razi A, Soroushmehr R, et al. Game Theoretic Approach for Systematic Feature Selection; Application in False Alarm Detection in Intensive Care Units. Entropy (Basel). 2018;20(3)doi: 10.3390/e20030190.
Afghah, F., Razi, A., Soroushmehr, R., Ghanbari, H., & Najarian, K. (2018). Game Theoretic Approach for Systematic Feature Selection; Application in False Alarm Detection in Intensive Care Units. Entropy (Basel, Switzerland), 20(3), . https://doi.org/10.3390/e20030190
Afghah, Fatemeh, et al. "Game Theoretic Approach for Systematic Feature Selection; Application in False Alarm Detection in Intensive Care Units." Entropy (Basel, Switzerland) vol. 20,3 (2018). doi: https://doi.org/10.3390/e20030190
Afghah F, Razi A, Soroushmehr R, Ghanbari H, Najarian K. Game Theoretic Approach for Systematic Feature Selection; Application in False Alarm Detection in Intensive Care Units. Entropy (Basel). 2018 Mar 12;20(3). doi: 10.3390/e20030190. PMID: 33265281; PMCID: PMC7512707.
Copy Download .nbib Format: NLM
The effect of time and temperature on shelf life of essential oil composition of .

Natural product research

Farahbakhsh J, Najafian S, Hosseinifarahi M, Gholipour S.
PMID: 32498558
Nat Prod Res. 2020 Jun 05;1-5. doi: 10.1080/14786419.2020.1771711. Epub 2020 Jun 05.

No abstract available.

Cite
Farahbakhsh J, Najafian S, Hosseinifarahi M, et al. The effect of time and temperature on shelf life of essential oil composition of . Nat Prod Res. 2020;1-5doi: 10.1080/14786419.2020.1771711.
Farahbakhsh, J., Najafian, S., Hosseinifarahi, M., & Gholipour, S. (2020). The effect of time and temperature on shelf life of essential oil composition of . Natural product research, 1-5. https://doi.org/10.1080/14786419.2020.1771711
Farahbakhsh, Jahangir, et al. "The effect of time and temperature on shelf life of essential oil composition of ." Natural product research vol. (2020): 1-5. doi: https://doi.org/10.1080/14786419.2020.1771711
Farahbakhsh J, Najafian S, Hosseinifarahi M, Gholipour S. The effect of time and temperature on shelf life of essential oil composition of . Nat Prod Res. 2020 Jun 05;1-5. doi: 10.1080/14786419.2020.1771711. Epub 2020 Jun 05. PMID: 32498558.
Copy Download .nbib Format: NLM
Morbilliform exanthem associated with COVID-19.

JAAD case reports

Najarian DJ.
PMID: 32313826
JAAD Case Rep. 2020 Apr 20;6(6):493-494. doi: 10.1016/j.jdcr.2020.04.015. eCollection 2020 Jun.

No abstract available.

Cite
Najarian DJ. Morbilliform exanthem associated with COVID-19. JAAD Case Rep. 2020;6(6):493-494doi: 10.1016/j.jdcr.2020.04.015.
Najarian, D. J. (2020). Morbilliform exanthem associated with COVID-19. JAAD case reports, 6(6), 493-494. https://doi.org/10.1016/j.jdcr.2020.04.015
Najarian, David James. "Morbilliform exanthem associated with COVID-19." JAAD case reports vol. 6,6 (2020): 493-494. doi: https://doi.org/10.1016/j.jdcr.2020.04.015
Najarian DJ. Morbilliform exanthem associated with COVID-19. JAAD Case Rep. 2020 Apr 20;6(6):493-494. doi: 10.1016/j.jdcr.2020.04.015. eCollection 2020 Jun. PMID: 32313826; PMCID: PMC7167547.
Copy Download .nbib Format: NLM
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience.

Medicines (Basel, Switzerland)

Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L, Schirrmacher V, Nazarian J, Stuecker W.
PMID: 32438648
Medicines (Basel). 2020 May 19;7(5). doi: 10.3390/medicines7050029.

No abstract available.

Cite
Van Gool SW, Makalowski J, Bonner ER, et al. Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel). 2020;7(5)doi: 10.3390/medicines7050029.
Van Gool, S. W., Makalowski, J., Bonner, E. R., Feyen, O., Domogalla, M. P., Prix, L., Schirrmacher, V., Nazarian, J., & Stuecker, W. (2020). Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel, Switzerland), 7(5), . https://doi.org/10.3390/medicines7050029
Van Gool, Stefaan W, et al. "Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience." Medicines (Basel, Switzerland) vol. 7,5 (2020). doi: https://doi.org/10.3390/medicines7050029
Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L, Schirrmacher V, Nazarian J, Stuecker W. Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience. Medicines (Basel). 2020 May 19;7(5). doi: 10.3390/medicines7050029. PMID: 32438648; PMCID: PMC7281768.
Copy Download .nbib Format: NLM
Late Cardiotoxicity in MS Patients Treated with Mitoxantrone.

International journal of preventive medicine

Najafian J, Nasri A, Etemadifar M, Salehzadeh F.
PMID: 31921403
Int J Prev Med. 2019 Dec 10;10:211. doi: 10.4103/ijpvm.IJPVM_477_17. eCollection 2019.

CONTEXT: Mitoxantrone (MTX) is an antracyclin drug that is used for treatment of patients with chronic refractory multiple sclerosis (MS). Congestive heart failure (CHF) is a rare complication of this drug that may occur early, during therapy, or late,...

Cite
Najafian J, Nasri A, Etemadifar M, et al. Late Cardiotoxicity in MS Patients Treated with Mitoxantrone. Int J Prev Med. 2019;10:211doi: 10.4103/ijpvm.IJPVM_477_17.
Najafian, J., Nasri, A., Etemadifar, M., & Salehzadeh, F. (2019). Late Cardiotoxicity in MS Patients Treated with Mitoxantrone. International journal of preventive medicine, 10211. https://doi.org/10.4103/ijpvm.IJPVM_477_17
Najafian, Jamshid, et al. "Late Cardiotoxicity in MS Patients Treated with Mitoxantrone." International journal of preventive medicine vol. 10 (2019): 211. doi: https://doi.org/10.4103/ijpvm.IJPVM_477_17
Najafian J, Nasri A, Etemadifar M, Salehzadeh F. Late Cardiotoxicity in MS Patients Treated with Mitoxantrone. Int J Prev Med. 2019 Dec 10;10:211. doi: 10.4103/ijpvm.IJPVM_477_17. eCollection 2019. PMID: 31921403; PMCID: PMC6941302.
Copy Download .nbib Format: NLM
Temporomandibular Joint Osteoarthritis Diagnosis Using Privileged Learning of Protein Markers.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Zhang W, Bianchi J, Turkestani NA, Le C, Deleat-Besson R, Ruellas A, Cevidanes L, Yatabe M, Goncalves J, Benavides E, Soki F, Prieto J, Paniagua B, Najarian K, Gryak J, Soroushmehr R.
PMID: 34891638
Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:1810-1813. doi: 10.1109/EMBC46164.2021.9629990.

Diagnosis of temporomandibular joint (TMJ) Osteoarthritis (OA) before serious degradation of cartilage and subchondral bone occurs can help prevent chronic pain and disability. Clinical, radiomic, and protein markers collected from TMJ OA patients have been shown to be predictive...

Cite
Zhang W, Bianchi J, Turkestani NA, et al. Temporomandibular Joint Osteoarthritis Diagnosis Using Privileged Learning of Protein Markers. Annu Int Conf IEEE Eng Med Biol Soc. 2021;2021:1810-1813doi: 10.1109/EMBC46164.2021.9629990.
Zhang, W., Bianchi, J., Turkestani, N. A., Le, C., Deleat-Besson, R., Ruellas, A., Cevidanes, L., Yatabe, M., Goncalves, J., Benavides, E., Soki, F., Prieto, J., Paniagua, B., Najarian, K., Gryak, J., & Soroushmehr, R. (2021). Temporomandibular Joint Osteoarthritis Diagnosis Using Privileged Learning of Protein Markers. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 20211810-1813. https://doi.org/10.1109/EMBC46164.2021.9629990
Zhang, Winston, et al. "Temporomandibular Joint Osteoarthritis Diagnosis Using Privileged Learning of Protein Markers." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2021 (2021): 1810-1813. doi: https://doi.org/10.1109/EMBC46164.2021.9629990
Zhang W, Bianchi J, Turkestani NA, Le C, Deleat-Besson R, Ruellas A, Cevidanes L, Yatabe M, Goncalves J, Benavides E, Soki F, Prieto J, Paniagua B, Najarian K, Gryak J, Soroushmehr R. Temporomandibular Joint Osteoarthritis Diagnosis Using Privileged Learning of Protein Markers. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:1810-1813. doi: 10.1109/EMBC46164.2021.9629990. PMID: 34891638.
Copy Download .nbib Format: NLM
Patient Specific Classification of Dental Root Canal and Crown Shape.

Shape in Medical Imaging : International Workshop, ShapeMI 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, 2020, Proceedings

Dumont M, Prieto JC, Brosset S, Cevidanes L, Bianchi J, Ruellas A, Gurgel M, Massaro C, Castillo AAD, Ioshida M, Yatabe M, Benavides E, Rios H, Soki F, Neiva G, Aristizabal JF, Rey D, Alvarez MA, Najarian K, Gryak J, Styner M, Fillion-Robin JC, Paniagua B, Soroushmehr R.
PMID: 33385170
Shape Med Imaging (2020). 2020 Oct;12474:145-153. doi: 10.1007/978-3-030-61056-2_12. Epub 2020 Oct 03.

This paper proposes machine learning approaches to support dentistry researchers in the context of integrating imaging modalities to analyze the morphology of tooth crowns and roots. One of the challenges to jointly analyze crowns and roots with precision is...

Cite
Dumont M, Prieto JC, Brosset S, et al. Patient Specific Classification of Dental Root Canal and Crown Shape. Shape Med Imaging (2020). 2020;12474:145-153doi: 10.1007/978-3-030-61056-2_12.
Dumont, M., Prieto, J. C., Brosset, S., Cevidanes, L., Bianchi, J., Ruellas, A., Gurgel, M., Massaro, C., Castillo, A. A. D., Ioshida, M., Yatabe, M., Benavides, E., Rios, H., Soki, F., Neiva, G., Aristizabal, J. F., Rey, D., Alvarez, M. A., Najarian, K., Gryak, J., Styner, M., Fillion-Robin, J. C., Paniagua, B., & Soroushmehr, R. (2020). Patient Specific Classification of Dental Root Canal and Crown Shape. Shape in Medical Imaging : International Workshop, ShapeMI 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, 2020, Proceedings, 12474145-153. https://doi.org/10.1007/978-3-030-61056-2_12
Dumont, Maxime, et al. "Patient Specific Classification of Dental Root Canal and Crown Shape." Shape in Medical Imaging : International Workshop, ShapeMI 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, 2020, Proceedings vol. 12474 (2020): 145-153. doi: https://doi.org/10.1007/978-3-030-61056-2_12
Dumont M, Prieto JC, Brosset S, Cevidanes L, Bianchi J, Ruellas A, Gurgel M, Massaro C, Castillo AAD, Ioshida M, Yatabe M, Benavides E, Rios H, Soki F, Neiva G, Aristizabal JF, Rey D, Alvarez MA, Najarian K, Gryak J, Styner M, Fillion-Robin JC, Paniagua B, Soroushmehr R. Patient Specific Classification of Dental Root Canal and Crown Shape. Shape Med Imaging (2020). 2020 Oct;12474:145-153. doi: 10.1007/978-3-030-61056-2_12. Epub 2020 Oct 03. PMID: 33385170; PMCID: PMC7773155.
Copy Download .nbib Format: NLM
Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved .

Drug metabolism and disposition: the biological fate of chemicals

Li J, Liu J, Zhang X, Clausen V, Tran C, Arciprete M, Wang Q, Rocca C, Guan LH, Zhang G, Najarian D, Xu Y, Smith P, Wu JT, Chong S.
PMID: 33941543
Drug Metab Dispos. 2021 Jul;49(7):572-580. doi: 10.1124/dmd.121.000381. Epub 2021 May 03.

Givosiran is an

Cite
Li J, Liu J, Zhang X, et al. Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved . Drug Metab Dispos. 2021;49(7):572-580doi: 10.1124/dmd.121.000381.
Li, J., Liu, J., Zhang, X., Clausen, V., Tran, C., Arciprete, M., Wang, Q., Rocca, C., Guan, L. H., Zhang, G., Najarian, D., Xu, Y., Smith, P., Wu, J. T., & Chong, S. (2021). Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved . Drug metabolism and disposition: the biological fate of chemicals, 49(7), 572-580. https://doi.org/10.1124/dmd.121.000381
Li, Jing, et al. "Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved ." Drug metabolism and disposition: the biological fate of chemicals vol. 49,7 (2021): 572-580. doi: https://doi.org/10.1124/dmd.121.000381
Li J, Liu J, Zhang X, Clausen V, Tran C, Arciprete M, Wang Q, Rocca C, Guan LH, Zhang G, Najarian D, Xu Y, Smith P, Wu JT, Chong S. Nonclinical Pharmacokinetics and Absorption, Distribution, Metabolism, and Excretion of Givosiran, the First Approved . Drug Metab Dispos. 2021 Jul;49(7):572-580. doi: 10.1124/dmd.121.000381. Epub 2021 May 03. PMID: 33941543.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 187 entries